Delivery Order SPE2DB22D7058-SPE2DB25FSWH5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Armour Thyroid 90 mg tablets in a quantity of 100 units, valued at $2,122.76. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order valued at $1,576.11 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 90 mg, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,389.28 to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 90 mg on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitive award, issued on a firm fixed price basis with no set-aside designation, represents a single delivery order fulfillment for pharmaceutical supply to support federal medical procurement needs. The vendor, headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a $1,033.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Armour Thyroid 30 mg on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order represents a small-value...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on March 14, 2025, for the supply of Armour Thyroid 90 mg tablets (100-count units) with a contract ceiling value of $2,847.42. This is a firm fixed-price delivery order with an ultimate completion date of March 17, 2025, and represents a non-competitive set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,522.70, is for the delivery of Armour Thyroid 15 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,622.86 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Armour Thyroid 60 mg tablets in 100-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen for providing a comprehensive range of pharmaceutical and medical supplies to support military...
- This delivery order, valued at $1,958.68, was awarded on October 24, 2025, to AmerisourceBergen Drug Corp for the supply of Armour Thyroid 120 mg tablets (100-count units) to support federal medical procurement needs. The contract is non-set-aside and competitively awarded, utilizing firm fixed pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for the Defense Logistics Agency (DLA), which funds...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Armour Thyroid 90 mg tablets. The $17,270.97 firm-fixed-price contract has a performance period ending on September 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to procure a comprehensive range of pharmaceutical and medical...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,163.57 firm-fixed-price contract is for the delivery of 4,567,866,841 units of Armour Thyroid 60 mg tablets by April 11, 2025. The contract is not set aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
- SPE2DB22D7058Indefinite Delivery Contract
- SPE2DB22D7058-SPE2DB25FSWH5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,097.11 to AmerisourceBergen Drug Corp for Armour Thyroid 60 mg tablets (100-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/26/25 |